INTRODUCTION
A few studies have concerned the behaviour of actinides after inhalation of (U, Pu)O 2 powders containing from 1 to 30% Pu which were regarded as homogeneous solid solutions (Stanley et al., 1982; Talbot and Baker, 1989; Morgan and Black, 1989; Lataillade et al., 1995) . The results suggested that transfer of Pu to the extra-pulmonary organs increased as the U/Pu or the 238 Pu/total Pu ratio increased. We have recently shown that inhaled (U, Pu)O 2 from a mixed oxide powder containing 5.3% Pu was heterogeneous at the nanometric level in terms of U/Pu ratio. Most of the inhaled particles from an aerosol of this powder corresponded to "pure" UO 2 and "pure" PuO 2 (Massiot et al., 1996a,b) .
The aim of this work was to provide experimental results on the biological behaviour of transuranium elements in lungs and their retention in extrapulmonary organs after inhalation of this "heterogeneous" (U, Pu)O 2 powder. Moreover, an estimate of the efficacy of a DTPA treatment on the Pu retention values has been performed after a repeated daily treatment for one week and, the chemical, and the isotopic compositions have been determined in the different organs studied.
METHODS
Two groups of 20 male Sprague-Dawley rats, referred to as group I and group II, were exposed at 3 months of age to the (U, Pu)O 2 aerosol containing 5.3%. The Pu used for the mixed oxide fabrication contained 1.1% of 238 Pu, 8.0% of 241 Pu and, at the time of the experiment, 11% of the total a activity was due to 241 Am. The aerosol was obtained by nebulization of the powder using our specific device as previously described (Andre et al., 1989) . Two hours later, six animals from group II received an intramuscular injection of DTPA (30 umol kg" 1 ) and this treatment was repeated daily for 6 days.
Rats were killed under pentobarbital anaesthesia (40 mg kg" 1 ) at different times after the aerosol exposures. The amounts of Pu and Am in lungs, liver, femurs and kidneys were measured by a-and y-ray spectrometry. For some animals, in vivo counting was performed by X-and/or y-ray spectrometry using an argon methane proportional counter or a Nal detector. Liquid scintillation measurements were performed on mineralized samples with or without specific solvent extraction of Pu (Keough and Powers, 1970) and for total a, with a scintillation medium adapted for Inhalation of (U, Pu)O 2 in the rat acid solution (Packard, instagel+).
241
Pu amounts were estimated by liquid scintillation assuming a counting yield similar to that of tritium. Alpha spectrometry was performed after actinide precipitation with lanthane fluoride.
RESULTS
The initial lung burdens measured on day 4 after exposure for group I and on day 7 after exposure for group II. These burdens, expressed as total a emissions were 4.3 kBq {SD = 0.7, n = 4) and 15.0 kBq (SD = 6.0, n = 6) for groups I and II, respectively.
The lung clearances of the two animal groups for the first 110 days after exposure are shown in Fig. 1 . A single exponential function with a half life of about 60 days was observed for the lowest initial lung burden (group I), whereas the clearance process appeared almost entirely inhibited for the highest initial lung burden (group II). In this latter animal group, four rats of the five animals remaining alive after 110 days died before day 160 post-exposure.
On day 7 post-exposure, the DTPA treatment performed on group II did not modify significantly the pulmonary retention of Pu as compared to the untreated controls. However, this DTPA treatment induced a significant decrease of the amount of Pu retained in liver and kidneys that corresponded to at least a 50% decrease as compared to controls (Table 1) . Table 2 shows, in group II, that the chemical and isotopic compositions of the actinide retentions in lungs, liver, kidneys and femurs, measured 7 days after exposure, were very similar to those provided for this (U, Pu)O 2 powder (Table 3) . On day 50 post-exposure, preliminary results suggested that the cumulated retention of actinides in the extra-pulmonary organs could correspond to more than 1.3% of the initial lung burden. Although the inhaled (U, Pu)O 2 particles were heterogeneous, the isotopic and chemical compositions of the initial lung deposit were very similar to those provided for the mixed oxide powder. Further studies are in progress to characterize these compositions in the different organs as a function of time following inhalation.
Two different clearance processes have been described during the first weeks following inhalation of "insoluble" particles in the rat. The first one, observed during the first 7-10 days post-exposure, corresponds to the mucociliary clearance of the upper airways. The second one, observed for 200-300 days, corresponds to alveolar migration to the upper respiratory tract via the bronchial tree lumen. After inhalation of 239 PuO 2 , a gradual inhibition of the first clearance process has been reported in the range of initial lung burdens from 0.7 to 9 kBq (Sanders et al., 1993) . Alteration of the second process was induced at higher initial lung burden with a nearly total inhibition for initial lung burden at 3.7 kBq (Sanders, 1972) . In our experimental conditions, we could only study this second process. The clearance was nearly entirely inhibited for an initial lung burden at 15 kBq, whereas the half life observed at 4.3 kBq was quite similar to the value we have reported in the same strain of rat after exposure to a (U, Pu)O 2 aerosol containing 20% of Pu or industrial PuO 2 (Lataillade et al., 1995) . However, this half life was about twice that measured after inhalation of Fe 2 O 3 (Fritsch and Masse, 1992) or after inhalation of 239 PuO 2 for low initial lung burden (Lundgren et al., 1995) . Such a difference might be explained by the high radiotoxicity due to the heterogeneity of the (U, Pu)O 2 particles used (Massiot et al., 1996a,b) . Further studies are in progress to determine if the alveolar macrophage clearance parameters could be altered, even at a low initial lung burden, as a function of the specific alpha activity of the inhaled particles.
To our knowledge, only one study has concerned the effect of a DTP A treatment on Pu extra-pulmonary retention after oxide inhalation (Fukuda et al, 1996) . In this study, the optimal treatment corresponded to intraperitoneal administration (150 (imol kg" 1 ) performed one day after exposure that was repeated daily for 5 days and then addition of DTP A to the drinking water. In this case, no significant diminution of Pu extra-pulmonary retention could be observed. In our study, a significant decorporation was observed that could mainly be due to the early treatment performed 2 h after exposure. Thus, our results demonstrate the efficacy of an early DTPA treatment to decrease Pu retention in extra-pulmonary organs after inhalation of (U, Pu)O 2 .
Our preliminary results on the transfer of transuranium elements to the extra-pulmonary organs were in the range of those reported in the rat after inhalation of (U, Pu)O 2 (Stanley et al, 1982; Lataillade et al, 1995) .
In conclusion, these preliminary results provide new information on the behaviour of transuranium elements after exposure to (U, Pu)O 2 aerosols. New questions, especially about lung clearance alterations as a function of the radiotoxicity of the inhaled particles and their heterogeneity, and about the efficacy of a DTPA treatment following inhalation of actinide oxides, arise. This justifies the need for further studies to provide new experimental data.
